Barclays Cuts Crocs (NASDAQ:CROX) Price Target to $125.00

Crocs (NASDAQ:CROXFree Report) had its price objective cut by Barclays from $164.00 to $125.00 in a research note released on Tuesday, Benzinga reports. They currently have an overweight rating on the textile maker’s stock.

A number of other equities analysts also recently issued reports on CROX. KeyCorp lifted their price objective on shares of Crocs from $149.00 to $155.00 and gave the stock an “overweight” rating in a report on Thursday, September 26th. Guggenheim started coverage on shares of Crocs in a report on Wednesday, October 9th. They set a “buy” rating and a $182.00 price objective on the stock. Wedbush reaffirmed an “outperform” rating and set a $170.00 price objective on shares of Crocs in a report on Monday, July 29th. Raymond James downgraded shares of Crocs from a “strong-buy” rating to an “outperform” rating and set a $164.00 price objective on the stock. in a report on Friday, August 2nd. Finally, Williams Trading raised shares of Crocs from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $135.00 to $163.00 in a report on Thursday, August 22nd. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $159.33.

Check Out Our Latest Research Report on CROX

Crocs Stock Performance

Shares of CROX stock opened at $111.58 on Tuesday. The firm has a market capitalization of $6.63 billion, a PE ratio of 8.39, a price-to-earnings-growth ratio of 1.35 and a beta of 1.99. The firm has a fifty day simple moving average of $137.69 and a two-hundred day simple moving average of $138.65. The company has a current ratio of 1.50, a quick ratio of 0.95 and a debt-to-equity ratio of 0.93. Crocs has a 12 month low of $74.00 and a 12 month high of $165.32.

Crocs (NASDAQ:CROXGet Free Report) last announced its quarterly earnings results on Thursday, August 1st. The textile maker reported $4.01 EPS for the quarter, beating analysts’ consensus estimates of $3.59 by $0.42. The business had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.10 billion. Crocs had a net margin of 20.02% and a return on equity of 53.20%. Crocs’s quarterly revenue was up 3.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $3.59 EPS. Analysts forecast that Crocs will post 12.88 EPS for the current fiscal year.

Insider Buying and Selling at Crocs

In other Crocs news, Director Douglas J. Treff sold 10,594 shares of the company’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $132.38, for a total transaction of $1,402,433.72. Following the sale, the director now directly owns 81,254 shares of the company’s stock, valued at $10,756,404.52. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other Crocs news, Director John B. Replogle acquired 1,996 shares of the company’s stock in a transaction on Friday, August 2nd. The shares were acquired at an average cost of $123.96 per share, with a total value of $247,424.16. Following the completion of the acquisition, the director now directly owns 7,064 shares in the company, valued at $875,653.44. This trade represents a 0.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Douglas J. Treff sold 10,594 shares of the company’s stock in a transaction dated Thursday, August 8th. The shares were sold at an average price of $132.38, for a total value of $1,402,433.72. Following the sale, the director now owns 81,254 shares in the company, valued at approximately $10,756,404.52. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.72% of the company’s stock.

Institutional Investors Weigh In On Crocs

Several hedge funds and other institutional investors have recently modified their holdings of CROX. National Bank of Canada FI increased its position in shares of Crocs by 8,437.1% during the second quarter. National Bank of Canada FI now owns 182,695 shares of the textile maker’s stock valued at $26,993,000 after buying an additional 180,555 shares during the period. Pacer Advisors Inc. increased its position in shares of Crocs by 15.1% in the second quarter. Pacer Advisors Inc. now owns 1,091,097 shares of the textile maker’s stock worth $159,235,000 after purchasing an additional 142,944 shares during the last quarter. Marshall Wace LLP bought a new position in shares of Crocs in the second quarter worth approximately $19,598,000. LSV Asset Management increased its position in shares of Crocs by 73.3% in the first quarter. LSV Asset Management now owns 300,413 shares of the textile maker’s stock worth $43,199,000 after purchasing an additional 127,100 shares during the last quarter. Finally, Distillate Capital Partners LLC bought a new position in shares of Crocs in the second quarter worth approximately $13,483,000. 93.44% of the stock is currently owned by institutional investors.

Crocs Company Profile

(Get Free Report)

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.

Further Reading

Analyst Recommendations for Crocs (NASDAQ:CROX)

Receive News & Ratings for Crocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crocs and related companies with MarketBeat.com's FREE daily email newsletter.